No 05+06/2004 » Abstract
Understanding the Clinical Biochemistry of N-Terminal Pro-B-Type Natriuretic Peptide: the Prerequisite for Its Optimal Clinical Use
by Mauro Panteghini, Aldo Clerico
With the introduction of the first rapid, fully automated assay for N-terminal pro-B-type natriuretic peptide (NtproBNP) determination, clinical laboratories are now able to transfer a number of preliminary information derived from pilot research experiences to the context of clinical cardiology. Some confounding factors may, however, affect the interpretation of the Nt-proBNP test and its clinical value. The objective of this review is to highlight and discuss these potentially confounding variables.
Clin. Lab. 2004;50(5-6):325-31.
Buy Fulltext PDF
Print
Fri 18th May, 2012
Indexed by CAS ONLINE, CHEMICAL ABSTRACTS, Current Advances in Clinical Chemistry, EMBASE / Excerpta Medica, Elsevier BIOBASE / Current Awareness in Biological Sciences, Index Medicus, ISI Document Solution and MEDLINE; Journal IMPACT FACTOR 0.821 / 2010, 1.056 / 5-Year



